Parkside Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,124
Closed -$253K 82
2024
Q3
$253K Hold
2,124
0.06% 75
2024
Q2
$303K Hold
2,124
0.08% 66
2024
Q1
$275K Buy
2,124
+24
+1% +$3.1K 0.07% 73
2023
Q4
$217K Sell
2,100
-194
-8% -$20.1K 0.06% 76
2023
Q3
$209K Buy
+2,294
New +$209K 0.06% 77